Samsung Bioepis Joins Biosimilar Lucentis Fray As It Unveils Phase III Plans

 
• By Jung Won Shin
  
Samsung Bioepis
Samsung Bioepis Headquarters in South Korea • Source: Samsung Bioepis

More from R&D

More from Scrip